T1	Participants 129 140	young males
T2	Participants 370 417	young males with hereditary androgenic alopecia
T3	Participants 449 528	diagnosis was alopecia with a mild to moderate perifollicular inflammation zone
T4	Participants 553 685	20 subjects who received two tablets of ViviScal once daily and 20 who received two tablets of fish extract once daily for 6 months.
T5	Participants 788 892	Most patients had been treated with long-term topical 2% minoxidil for 1 year or more prior to the study
T6	Participants 1065 1197	In the fish extract treatment group three patients withdrew from the study before the fourth month due to lack of therapeutic effect
